Advertisement
The Lancet Neurology

About The Lancet Neurology

About the journal

The Lancet Neurology was launched in May, 2002, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to neurologists worldwide.

Reputation and Impact

The Lancet Neurology has an Impact Factor of 30.039® and ranks first among clinical neurology journals (2019 Journal Citation Reports®, Clarivate Analytics 2020). The Lancet Neurology provides an authoritative and independent forum for the highest quality clinical neurology research, reviews, and news in all areas of global clinical neurology with a particular focus in the research and treatment of stroke, MS, movement disorders, epilepsy, headache, and dementia.

Information for Authors

The Lancet Neurology considers any original research contribution that advocates change in, or illuminates, neurological clinical practice, and publishes interesting and informative reviews on any topic connected with neurology. The journal publishes a range of article types that encompass all aspects of neurological medicine: Reflection and Reaction, In Context, Article, Review, Meta-analysis, Rapid Review, and Personal View. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal.

The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

If your question is not addressed on these pages then the journal's editorial staff (+44 [0] 20 7424 4272) will be pleased to help (email [email protected]).

About our content

The Lancet Neurology publishes interesting and informative reviews on any topic connected with neurology, and considers any original research contribution that advocates change in, or illuminates, neurological clinical practice. Topics include, but are not limited to:

  • Cerebrovascular disease
  • Dementia/Alzheimer’s disease
  • Epilepsy and seizures
  • Genetics
  • Headache and migraine
  • Neurological infections
  • Motor neuron disease/amyotrophic lateral sclerosis
  • Movement disorders
  • Multiple sclerosis
  • Neuromuscular disorders
  • Peripheral nerve disorders
  • Paediatric neurology
  • Sleep disorders
  • Trauma
  • Neurological tumours

Fast-track publication

All original research Articles judged eligible for consideration by the journal's staff will be peer-reviewed within 72 h and, if accepted, published in 4-8 weeks. All accepted Articles will be published online first before appearing in the print journal. The online article does not differ from the version subsequently published in print and is citable by the digital object identifier (DOI) assigned at the time of online publication. All other manuscripts will be peer-reviewed via our standard process.

Manuscript submission

To submit your manuscript to The Lancet Neurology please visit : http://www.editorialmanager.com/thelancetneurology

Publishing excellence

As trusted sources of information, the Lancet journals set extremely high standards for publishing, and we are committed to ensuring that our editorial processes meet our standards of excellence. From acceptance of your paper through to publication and beyond, our in-house teams of professional Editors, Assistant Editor, Illustrators, Production Editors, and Marketing and Communications experts can provide personal attention and guidance to strengthen the accuracy, accessibility, timeliness, and impact of your research.

About the Editorial team

Elena Becker-Barroso, Editor-in-Chief

Dr Elena Becker-Barroso became Editor-in-Chief of The Lancet Neurology in July 2012 after serving as Acting Editor for 1 year, 2 years as Deputy Editor, and 3 years as Senior Editor for the journal. She earned her PhD in molecular biology from the Instituto de Microbiologia-Bioquimica, CSIC-Universidad de Salamanca (Salamanca, Spain) and did her postdoctoral training at the Skirball Institute of Biomolecular Medicine, New York University (New York, NY, USA).

Laura Hart, Deputy Editor

Laura Hart has held various editorial roles at The Lancet and The Lancet Neurology since 2004, including running The Lancet journals’ conference programme. Laura worked with The Lancet Neurology team on several successful conferences—in the fields of stroke, dementia, and NMDA receptor encephalitis—before being appointed Senior Editor in 2017. She studied clinical sciences at King's College London, UK, before completing a Master’s degree in clinical trials at the London School of Hygiene & Tropical Medicine, London, UK.
Heather Brown

Heather Brown, Senior Editor

Heather Brown has been a Senior Editor at The Lancet Neurology since 2008. She studied Biomedical Sciences at the University of Sheffield (Sheffield, UK), where she also completed a PhD on the role of cell adhesion molecules in axon guidance. She began her editorial career as an Assistant Editor with Trends in Neurosciences in 2001 and was also an in-house Editor at Current Opinion in Neurobiology before becoming Senior Assistant Editor at The Lancet Neurology in 2007.
Michael Lynskey

Michael Lynskey, Senior Editor

Michael Lynskey joined The Lancet Neurology as a Senior Editor in 2020. He studied Psychology at Otago University (New Zealand) and also completed a PhD in Epidemiology there. Before joining The Lancet Neurology he held academic appointments in Australia, the USA, and the UK.
Melanie Wulff

Melanie Wulff, Senior Editor

Melanie Wulff has been a Senior Editor at The Lancet Neurology since 2017. She studied psychology as a Major and neurology as a Minor at the University in Regensburg (Regensburg, Germany), before completing a PhD on the role of affordance on perception in patients with stroke at the University of Birmingham (Birmingham, UK). Her postdoctoral research focused on real-time fMRI neurofeedback in adolescents with ADHD at King’s College London (London, UK).

About the advisory board

The advisory board of the journal consists of key opinion leaders who have lent their expertise and support to The Lancet Neurology.

Ombudsman

Our ombudsman can: investigate delays in handling submitted manuscripts; discourtesy; failure to follow outlined procedures; failure to take reasonable account of representations to us by authors and readers; and challenges to the publishing ethics of the journal. If you have concerns about any of the above, please first contact an editor or the editorial inbox [email protected]; an editor will then respond to you (often, an editor can respond satisfactorily). If you remain dissatisfied with our response, please contact Malcolm Molyneux ([email protected])

Read more about the ombudsman and see our ombudsman's reports.

The Lancet Group’s Diversity Pledge and No All-Male Panel Policy

Read the Diversity Pledge and No All-Male Panel Policy

November 2020
Volume 19, Issue 11